Anti-CD65s Anticorps [VIM-2] (FITC) (A281919)

Ce produit est discontinué

Anti-CD65s Anticorps [VIM-2] (FITC) (A281919) a été abandonné et n'est plus disponible.

Voir tous les produits disponibles.

Nom du produit
Anti-CD65s Antibody [VIM-2]
Description du produit
Mouse anti Human CD65s:FITC
Spécificité
Mouse anti Human CD65s antibody, clone VIM-2 selectively recognizes the sialylated form of human CD65, known as CD65s (VIM-2 antigen), a leucocyte carbohydrate antigen expressed by granulocytes, monocytes and leukaemic cells of myelomonocytic lineage.CD65s is aberrantly expressed on some acute myeloid leukaemias (AML) and clone VIM-2 has been reliably used as a marker for distinguishing between mature and undifferentiated AML. During normal myelopoiesis, expression of CD65s follows the disappearance of the progenitor antigen CD34.Cross-linking of the CD65s antigen using clone VIM-2, has been shown to induce phagocyte cytoplasmic calcium flux, oxidative burst and degranulation (Lund-Johansen et al. 1992).
Applications
Flow Cytometry
Reactivité
Human
Immunogène
THP1 (human acute monocytic leukaemia cells).
Hôte
Mouse
Clonalité
Monoclonal
Clone
VIM-2
Isotype
IgM
Conjuguer

FITC

Excitation: 490nm, Emission: 525nm

Purification
Ammonium sulphate precipitation.
Concentration
100 µg/ml
Forme du produit
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.09% Sodium Azide and 1% BSA.
Stockage
Store at 4°C. Do not freeze!
Avertissement
Ce produit est uniquement destiné à la recherche. Il n'est pas destiné à un usage diagnostique ou thérapeutique.
Haut